Mouse Frozen Mixed Tissue Microarray, Panel -3 from Zyagen Laboratories

Products	Mouse Frozen Mixed Tissue Microarray, Panel -3 from Zyagen Laboratories
Company	Zyagen Laboratories
Item	Mouse Frozen Mixed Tissue Microarray, Panel -3
Price	$450.00
Description	Zyagen tissue microarrays are derived from frozen embedded tissue blocks, which are subjected to rigorous quality control procedures to ensure the highest quality. Tissues of each array are manually assembled in one block, sectioned at a thickness of 7microns and mounted on coated slides. Sections are large (3-5mm in diameter) in comparison to core sections made using Tissue Arrayer. Arrays enable high throughput screening of large number of tissue specimens by immunohistochemistry and in situ hybridization. Tissues Represented: Kidney, Lung, Heart, Liver, Pancreas, Stomach, Intestine, Colon, Rectum, Tongue, Testis, Epididymis, Ductus Deference, Seminal Vesicle, Prostate, Ovary/Oviduct, Uterus, Skin, Spleen, Thymus, Skeletal muscle, Cerebellum, Cerebral cortex, and brain stem
Info	Zyagen Laboratories 10225 Barnes Canyon Road San Diego, CA 92121 Customer Service: 858-442-0704 Fax Number: 858-546-0736 Web Site: http://www.zyagen.com

NOTE: Price information is approximate list price and actual prices may vary.

TAG: Mouse Frozen Mixed Tissue Microarray Panel from Zyagen Laboratories

BLOCK-iT siRNA, Stealth and Custom RNA from Invitrogen

...atoms at the 9, 10, 12, and 13 positions. It is in...ntification of 13(S)-HODE by GC- or LC-mass spectr...noleic acid with plant and mammalian lipoxygenases...or cells to the endothelium at concentrations arou...

Adaptor BamH I-Sma I from Takara Mirus Bio

Cassette, Hind III from Takara Mirus Bio

Biology Products:

BLOCK-iT siRNA, Stealth and Custom RNA from Invitrogen 13(S)-HODE-d4, Deuterium Conjugated/Tagged from Cayman Chemical Adaptor BamH I-Sma I from Takara Mirus Bio Cassette, Hind III from Takara Mirus Bio

(Date:11/4/2009)...ancouver, BC - Lowly bacteria, it turns out, hold ...turing plants around the world clean up toxic wast..., specifically RDX, were invented back in World Wa...decades. These high-energy compounds are often us...ful version of TNT. , But with increased knowl...

(Date:11/4/2009)...he University of Oklahoma at Norman has received m...funding agencies as part of the federal stimulus p...ng received by OU researchers to $23 million. Thi...search ranging from archaeology to weather. , "T...atic approach to matching areasof scholarly excell...

(Date:11/4/2009)..., MADISON, N.J., Oct. 20 /PRNewswire-FirstCall/ -...e world,s leading provider of diagnostic testing, ...hird quarter ended September 30, 2009, income from....02 per diluted share, from $160 million, or $0.81... In 2008, third quarter results were reduced by a ...

[0] Genomic research will enable greener cleanup of military explosive test sites [0] OU achieves $10 million in stimulus grants for 33 projects on the Norman campus [0] Quest Diagnostics Reports Strong Performance in Third Quarter 2009

...his press release is available in German . , Wi...ecks above all at airports has been increased co...concerns the protection of passengers. Possibiliti...e offered by terahertz radiation. Before this radi...s to be measured quantitatively, so that damage to...

...erts from the worlds of law, geography, economics,...(University College London) on Friday September 19...es can become locally-rooted champions for global ...y to help bring about lasting change. The symposiu...elating Ecological Thinking, Learning and Research...

...logists at the University of Rochester have found ... evolved a previously unknown anti-cancer mechanis... mechanisms employed by humans or other large mamm...f Aging Cell. , Understanding this mechanism may ...ancers originate from stem cells and similar mecha...

Other Biology News:Checking people at airports -- with terahertz radiation 2 Universities develop a more sustainable future 2 Novel anti-cancer mechanism found in long-lived rodents 2

Checking people at airports -- with terahertz radiation Universities develop a more sustainable future Novel anti-cancer mechanism found in long-lived rodents

(Date:11/6/2009)...,, QUINCY, Mass., Nov. 6 Myrian...biotech developer and manufacturer of renewable b...preferred technology provider Uhde GmbH, one of th... "Uhde"), announced an alliance for the engineerin...,s biobased Succinic Acid plants based on renewabl...

(Date:11/6/2009)...,, CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Onc...lytics" or the "Company") today announced updated ...SIN(R) in patients with sarcomas metastatic to the...Connective Tissue Oncology Society Meeting held in...he poster presentation, entitled "A Phase II Study...

(Date:11/5/2009)...,, GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstC...ced its financial results for the third quarter en... of $3.6 million ($0.04 per share) for the three m...oss of $6.8 million ($0.08 per share) in the compa...eptember 30, 2009, GenVec,s net loss was $14.1 mil...

(Date:11/5/2009)...,, RANCHO CORDOVA, Calif., Nov. 5 /PRNewswire-F... a leading supplier of innovative products for pro...ed results for the first quarter of fiscal 2010. ,... Company reported revenues of $5.2 million, a 15 p...he first quarter a year ago. The Company said the ...

Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2 Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3 Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2 Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3 GenVec Reports Third Quarter 2009 Financial Results 2 GenVec Reports Third Quarter 2009 Financial Results 3 GenVec Reports Third Quarter 2009 Financial Results 4 GenVec Reports Third Quarter 2009 Financial Results 5 GenVec Reports Third Quarter 2009 Financial Results 6 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8

[0] Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants [0] Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting [0] GenVec Reports Third Quarter 2009 Financial Results [0] ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line